Studies related to Symptoms of Alzheimer’s and Fish Oil

Docosahexaenoic Acid Supplementation And Cognitive Decline In Alzheimer Disease: A Randomized Trial

Effect None
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 295
Sex Both Genders
Age Range 65+
Body Types Overweight, Average
Notes for this study:
2,000mg DHA from algae for 18 months failed to significantly delay symptoms associated with Alzheimer's disease or reduce the rate of cognitive decline as assessed by CDR and ADAS-cog rating scales. Similarly, the rate of brain atrophy was not affected.